BASF has signed an agreement to acquire significant parts of Bayer’s seed and non-selective herbicide businesses. Bayer intends to divest these assets to gain regulatory approval for its planned acquisition of Monsanto.
The all-cash purchase price is about $7 billion, subject to certain adjustments at closing.
Assets to be acquired include:
- Bayer’s global glufosinate-ammonium non-selective herbicide business, commercialized under the Liberty, Basta and Finale brands.
- Canola hybrids in North America under the InVigor brand using the LibertyLink trait technology, and oilseed rape, mainly in European markets.
- Cotton in the Americas and Europe as well as soybeans in the Americas.
- Bayer’s trait research and breeding capabilities for these crops and the LibertyLink trait and trademark.
- Related research and manufacturing facilities.
The transaction is subject to the closing of Bayer’s acquisition of Monsanto and approval by relevant authorities. It is expected to close in the first quarter of 2018.
“With this investment, we are seizing the opportunity to acquire highly attractive assets in key row crops and markets,” said Kurt Bock, Chairman of the Board of Executive Directors of BASF SE. “It will be a strategic complement to BASF’s well-established and successful crop protection business as well as to our own activities in biotechnology. The acquisition will further enhance our agricultural solutions offer, which is a core pillar of BASF’s portfolio.”
AgFax Weed Solutions
More than 1,800 commercial, R&D, breeding and production personnel will transfer from Bayer to BASF if the deal goes through. These employees are primarily located in the United States, Germany, Brazil, Canada and Belgium.